Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
D000081:Acetamides; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D004032:Diet; D004305:Dose-Response Relationship, Drug; D005260:Female; D005326:Fetal Proteins / Q000378:metabolism*; D005449:Fluorenes / Q000494:pharmacology*; D008113:Liver Neoplasms / Q000097:blood / Q000139:chemically induced*; D008297:Male; D009374:Neoplasms, Experimental / Q000097:blood / Q000139:chemically induced; D011230:Precancerous Conditions / Q000097:blood*; D011863:Radioimmunoassay; D051381:Rats; D012737:Sex Factors; D013268:Stimulation, Chemical; D013997:Time Factors
D000081:Acetamides; D002273:Carcinogens; D005326:Fetal Proteins; D005449:Fluorenes